Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-13
DOI
10.1007/s12325-021-01900-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cognitive behavioral therapy for menopausal symptoms
- (2020) M. S. Hunter CLIMACTERIC
- Treatment of Menopausal Vasomotor Symptoms with Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial
- (2019) Herman Depypere et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action
- (2018) Julia K. Prague et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
- (2017) Julia K Prague et al. LANCET
- Effects of Antidepressants on Sleep
- (2017) Adam Wichniak et al. Current Psychiatry Reports
- 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
- (2016) R. J. Baber et al. CLIMACTERIC
- A Direct Neurokinin B Projection from the Arcuate Nucleus Regulates Magnocellular Vasopressin Cells of the Supraoptic Nucleus
- (2016) R. Pineda et al. JOURNAL OF NEUROENDOCRINOLOGY
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
- (2015) Cynthia A. Stuenkel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes
- (2015) Bette Caan et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Placebo Improvement in Pharmacologic Treatment of Menopausal Hot Flashes
- (2015) Ellen W. Freeman et al. PSYCHOSOMATIC MEDICINE
- Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
- (2015) Nancy E. Avis et al. JAMA Internal Medicine
- The kisspeptin-GnRH pathway in human reproductive health and disease
- (2014) Karolina Skorupskaite et al. HUMAN REPRODUCTION UPDATE
- Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms
- (2014) Hadine Joffe et al. JAMA Internal Medicine
- Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushes
- (2013) Naomi E. Rance et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
- (2013) Emiliangelo Ratti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia
- (2013) Emiliangelo Ratti et al. SLEEP
- Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause
- (2012) David F. Archer et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms
- (2012) JoAnn V. Pinkerton et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms
- (2012) JoAnn V. Pinkerton et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- InactivatingKISS1Mutation and Hypogonadotropic Hypogonadism
- (2012) A. Kemal Topaloglu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms
- (2011) P. Bouchard et al. CLIMACTERIC
- Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats
- (2010) Helaine De Brito Gariepy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and Tolerability of Desvenlafaxine Succinate Treatment for Menopausal Vasomotor Symptoms
- (2010) Leon Speroff et al. OBSTETRICS AND GYNECOLOGY
- Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety
- (2009) David F. Archer et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Forebrain projections of arcuate neurokinin B neurons demonstrated by anterograde tract-tracing and monosodium glutamate lesions in the rat
- (2009) S.J. Krajewski et al. NEUROSCIENCE
- A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause
- (2008) David F. Archer et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Expression of the tachykinin receptor mRNAs in healthy human colon
- (2008) Nadia Jaafari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now